|

6 cycles chemotherapy Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • North Eastern German Society of Gynaecological Oncology1

Indications

  • Clear Cell Carcinoma1
  • Primary Peritoneal Carcinoma1
  • Fallopian Tube Cancer1
  • Ovarian Cancer1
  • Cancer1

Other1 trial

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.